Le Lézard
Classified in: Science and technology
Subjects: MAV, POL, FVT, CFG

UPDATE-- Media Advisory - Parliamentary Secretary Lauzon to make major high tech investment announcement


Parliamentary Secretary Stéphane Lauzon will make the announcement.

OTTAWA, Jan. 24, 2019 /CNW/ - Stéphane Lauzon, Parliamentary Secretary to the Minister of Veterans Affairs and Associate Minister of National Defence, on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development, will announce an important investment through the Strategic Innovation Fund.

 

Date:

Friday, January 25, 2019



Time:

1:00 p.m. (ET)



Location:

Nokia Canada Inc.
600 March Road
Kanata, Ontario

 

Follow Innovation, Science and Economic Development Canada on Twitter: @ISED_CA

 

SOURCE Innovation, Science and Economic Development Canada


These press releases may also interest you

at 00:00
XSOOH has always been at the forefront of hair care innovation, striving to deliver cutting-edge  products  that enhance the way customers achieve their desired looks. In a world where time is precious, XSOOH  proudly announces the launch of the...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

3 jui 2024
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

3 jui 2024
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...



News published on and distributed by: